Kim Allison

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies

Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination

Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2

Vaccination in Solid Organ Transplantation

Guillain–Barré Syndrome

The Burden of Respiratory Syncytial Virus Infection in Young Children

Correlates of vaccine protection from influenza and its complications

Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications

Vaccine adjuvants – understanding molecular mechanisms to improve vaccines

Interferons and viruses: an evolutionary arms race of molecular interactions

The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Influenza vaccine immunology

Issues Related to the Design and Interpretation of Clinical Trials of Salvage Therapy for Invasive Mold Infection

Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis

Prevention and Control of Seasonal Influenza with Vaccines

Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

The antigenic evolution of influenza: drift or thrift?

Discordant Rise in Galactomannan Antigenemia in a Patient with Resolving Aspergillosis, Renal Failure, and Ongoing Hemodialysis

Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer

Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

Recipients of Vaccine against the 1976 “Swine Flu” Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer

Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer